Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Argenx to acquire Unnatural Products in deal worth up to $1.15B

Argenx said Monday it will buy a macrocycle biotech that started out of a garage in a deal totaling up to about $1.15 billion. Argenx will pay $550 million upfront in cash with as much ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 9 November →